Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Will these five travel stocks weather the Covid-19 threat in 2022?
Consumer Stocks

Will these five travel stocks weather the Covid-19 threat in 2022?

Highlights Marriott International (NASDAQ: MAR) logged revenue of US$3.94 billion in Q3, FY21. American Airlines Group Inc. (NASDAQ: AAL) CEO Doug Parker will retire in March 2022. The revenue of Expedia Group, Inc. (NASDAQ: EXPE) jumped 97% Y...

Why did Dare Bioscience (DARE) stock jump Wednesday?
Healthcare Stocks

Why did Dare Bioscience (DARE) stock jump Wednesday?

Highlights Dare Bioscience Inc. (NASDAQ: DARE) received FDA approval for a new drug on Tuesday. Dare Bioscience’s stock price rose over 61% YTD. Its Xaciato drug is used in treating bacterial vaginosis in females. Shares of Dare Bio...

Grove Collaborative to go public in merger with Branson-backed SPAC
IPO

Grove Collaborative to go public in merger with Branson-backed SPAC

Highlights Grove said it would raise about US$87 million through PIPE (private investment in public equity) linked to the merger. The San Francisco-based startup Grove plans to use the proceeds to develop innovative products for eco-friendly h...

Cingulate Inc (CING) IPO: How to buy the stock?
IPO

Cingulate Inc (CING) IPO: How to buy the stock?

Highlights Cingulate is offering 4,166,666 shares of its common stock and warrants. The offering price is US$6 per share. The gross proceeds from the offering are expected to be around US$25 million. Biopharmaceutical company Cingulate In...